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X-raya b s t r a c t
Samarcandin 1, a natural sesquiterpene-coumarin, was isolated as well as elucidated from F. assa-foetida
which has significant effect in Iranian traditional medicine because of its medicinal attitudes. The crystal
structure of samarcandin was determined by single-crystal X-ray structure analysis. It is orthorhombic,
with unit cell parameters a = 10.8204 (5) Å, b = 12.9894 (7) Å, c = 15.2467 (9) Å, V = 2142.9 (2) Å3, space
group P212121 and four symmetry equivalent molecules in the unit cell. Samarcandin was isolated in
order to study for its theoretical studies as well as its cellular toxicity as anti-cancer drug against two
cancerous cells. In comparison with controls, our microscopic and MTT assay data showed that samarcan-
din suppresses cancer cell proliferation in a dose-dependent manner with IC50 = 11 lM and 13 for AGS
and WEHI-164 cell lines, respectively. Density functional theory (DFT) and time-dependent density func-
tional theory (TD-DFT) of the structure was computed by three functional methods and 6-311++G⁄⁄ stan-
dard basis set. The optimized molecular geometry and theoretical analysis agree closely to that obtained
from the single crystal X-ray crystallography. To sum up, the good correlations between experimental
and theoretical studies by UV, NMR, and IR spectra were found.
 2016 Elsevier Inc. All rights reserved.1. Introduction
Sesquiterpene-coumarins are a large group of natural com-
pounds whose structures are based on a C15 terpene moiety linked
through an ether linkage with the 7-hydroxy group. The origin of
sesquiterpene-coumarins are the families Apiaceae (Umbelliferae),
Asteraceae (Compositae) and Rutaceae. They find in the genera
such as Ferula, Heptapetra, Heraclum, Peucedanum, Angelica (Api-
aceae), Artemisia (Asteraceae) and Haplophyllum (Routaceae) [1].Among these genera, an array of different sesquiterpene-
coumarins have been reported from Ferula species. Thus, there is
a substantial attention to the chemistry and pharmacology of
plants belonging to the Ferula species which are traditionally used
for the treatment of various diseases such as asthma, epilepsy,
stomach-ache, flatulence, intestinal parasites, weak digestion and
influenza [2–5]. Recent biological studies on oleo-gum-resin of
Ferula species have markedly shown as antioxidant [6], anticonvul-
sant [7], antibacterial [8], antiviral [5], antifungal [9–11], cancer
chemopreventive [12,13], anti-diabetic [14], antispasmodic,
hypotensive [15], as well as molluscicidal [16]. As far as a huge
number of cyclic sesquiterpene-coumarins, including compounds
feselol, coladin, coladonin, isosamarcandin and mogoltacin,
isolated from F. gumosa, F. tunetana and F. Badrakema displayed
various effects against several human cancerous cell lines
[17–19], the purpose of the present study is to provide theoretical
studies as well as cellular toxicity of samarcandin, an isolated
sesquiterpene-coumarin from F. assa-foetida, based on its cytotoxic
characteristics on cancerous AGS (Stomach from human) and
28 S.H. Ghoran et al. / Bioorganic Chemistry 66 (2016) 27–32WEHI-164 (Skin from mouse fibrosarcoma) cells. In addition, it is
worth to mention that samarcandin (CCDC No. 1015760,
C24H32O5, refer to Fig. 1) was initially isolated from ethereal extract
of F. samarcandica Kor. and its infrared (IR) as well as UV spectra
were also studied [20,21]. Subsequently, its three-dimensional
structure along with absolute configuration was determined with
X-ray crystallography by Nasirov et al. [22]. However, theoretical
studies and cytotoxic activity on samarcandin has, to date, not
been carried out. Hence, in the present research, the chemical
structure of samarcandin 1 was elucidated by experimental NMR,
IR, UV as well as theoretical methodology using by B3LYP [23–
28] functional and 6-311++G⁄⁄ standard basis set.Fig. 1. Chemical structure of Samarcandin isolated from F. assa-foetida.
2. Experimental
2.1. Plant material
Oleo-gum-resin obtained from Ferula assa-foetida L. root were
collected from hills of Tangesorkh from Yasouj of Kohgiluyeh and
Boyer-Ahmad province, Iran, in May 2014. Tangesorkh is a swampy
area where F. assa-foetida’s is collected for the export outside Iran.
The plant was identified by Agriculture and Natural Recourses
Research Centre, Yasouj, Iran, and a voucher specimen (No. 4412)
was deposited in the Herbarium of the same institute.
2.2. Instruments and materials
All reagents and solvents for analysis were commercially avail-
able and used as received without further purifications. IR spectra
were recorded on a Perkin-Elmer FT-IR instrument, using KBr disks,
over the range 400–4000 cm1. The UV spectra in CHCl3 solvent
were measured by Shimadzo spectrophotometer. 1H and 13C
NMR experiments were carried out on a Bruker AV-400 NMR spec-
trometer with TMS as an internal standard. Column chromatogra-
phy was performed on 230–400 mesh silica gel (Merck, Germany).
TLC was performed on Merck F254 silica gel plates (10  10 cm)
(Merck, Germany). Spots on TLC were detected by UV254. X-ray
diffraction experiments were carried out on a Gemini four circle
kappa diffractometer of Agilent Technologies using mirrors-
collimated Mo Ka radiation (k = 0.7107 Å).
2.3. Extraction and isolation
Oleo-gum-resin obtained from F. assa-foetida L. (100 g) was
extracted with Et2O (250 mL) at reflux for 24 h. The extract was
concentrated under reduced pressure to obtain a residue (45 g).
The Et2O extract (7 g) was separated by chromatography using a
silica gel column and eluted with a gradient of n-hexane:EtOAc
(9.7:0.3, 9:1, 8:2, 7:3, 6:4, 5:5, 3:7 and 0:10 (v/v)) to give eight frac-
tions (FA-FH). Fraction FE1 (420 mg, n-hexane:EtOAc, 6:4) was puri-
fied by recrystallization by using n-hexane:EtOAc to obtain the
samarcandin as white crystals (61 mg, with Rf: 0.72 for n-
hexane:EtOAc, 96:4). It was shown by only one spot on TLC paper
under UV254 and there was no need for further purification.
2.4. X-ray crystal structure analysis of samarcandin
A single crystal of the dimensions 0.66 mm 
0.52 mm  0.40 mm for samarcandin was chosen for the X-ray
diffraction study. Crystallographic measurements were carried
out at 120 K with a four circle CCD diffractometer, Gemini of
Oxford diffraction, Ltd., with graphite-monochromated Mo Ka
radiation (k = 0.7107 Å), using Mo-Enhance fiber optics collimator
and the CCD detector Atlas. The crystal structure of samarcandin
was solved by program Superflip [29] and refined with Jana2006program package [30] by the full-matrix least-squares technique
on F2 [29]. The molecular structure plots were prepared by
ORTEP-III. All hydrogen atoms present in the structure model were
discernible in difference Fourier maps and could be refined to rea-
sonable geometry. According to common practice H atoms bonded
to C were kept in ideal positions with CAH = 0.96 Å while positions
of H atom bonded to O were refined freely. In both cases Uiso (H)
was set to 1.2Ueq (C,O). All non-hydrogen atoms were refined
using harmonic refinement. The hydrogen atoms of partially occu-
pied water molecule could not be found in difference Fourier map
and therefore they are absent in the structure model.
2.5. Computational procedures
The geometry optimization of samarcandin was studied by
using density functional theory (DFT) calculations in combination
with the B3LYP, BLYP and B3PW91 methods and 6-311++G⁄⁄ stan-
dard basis set [24,31,32]. All calculations were carried out with the
Gaussian 98 program [28]. The selected bond lengths, angles and
torsion angles of samarcandin are shown in Table 3. After full opti-
mization, the vibrational calculation was studied by B3LYP
method. The nuclear magnetic resonance NMR in our calculation
(B3LYP method) was verified by the gauge included atomic orbital
approach (GIAO) method [33,34]. We also performed Time-
dependent density functional theory (TD-DFT) calculations in gas
phase by B3LYP/6-311++G⁄⁄ level of theory. The harmonic fre-
quency calculation at the same levels is studied [35,36].
2.6. Measurements of cell growth inhibition
Details of measuring cell growth inhibition are explained
elsewhere [37]. Two cell lines including WEHI-164 and AGS (both
from Pasteur Institute, Tehran, Iran) were grown in Dulbecco’s
modified Eagle’s medium (DMEM; GIBCO, USA) containing 10%
fatal bovine serum (FBS; GIBCO, USA) at 37 C in a humidified
atmosphere of 5% CO2. Cell viability was measured by MTT
(3-[4,5-dimethylthiazol-2-yl] 2,5-iphenyltetrazolium bromide)
assay according to the manufacturer’s instructions (Sigma–Aldrich,
USA). Briefly, cancerous AGS and WEHI-164 cells and normal
fibroblasts were seeded onto 96-well plates and allowed to adhere
and grow overnight in 200 ll DMEM medium. The cells were then
incubated with fresh medium containing serial concentrations (0–
200 lM) of samarcandin dissolved in 1% DMSO for 48 h. Dendroso-
mal curcumin as an anti-proliferative compound was also
employed as positive control. Afterward, 20 ll of 5 mg/ml MTT
was added to each well and incubated for additional 4 h at 37 C
followed by addition of 200 ll of DMSO [37]. The relative cell via-
bility was determined at 540 nm by a 96-well plate reader (Biorad-
USA) and the concentration at which cell growth was inhibited by
Table 1
NMR spectroscopic data for Samarcandin 1 (in CDCl3).
Position dH (J in Hz) dC
S.H. Ghoran et al. / Bioorganic Chemistry 66 (2016) 27–32 2950% (IC50) was determined by standard curve method [38]. Each
experiment was carried out in triplicate wells and repeated at least
three times from each other.10a 1.54, td (13.4, 3) 32.35
10b 1.20, dd (13.4, 8)
20a 1.79, brt (13.4, 3) 24.80
20b 1.32, dd (13.4, 8)
30 3.41, broad signal 73.50
40 – 36.99
50 1.42, broad signal 47.79
60a 1.28, broad signal 19.54
60b 1.45, dd (11.9, 4)
70a 1.49, broad signal 43.97
70b 1.72, dd (11.9, 4)2.7. Study of morphological changes in treated cells
Based on our previous work, morphological changes of all can-
cer cell lines were studied under invert microscope (Nikon-Japan)
during treatment. Briefly, cells treated with 10 lM of samarcandin
and their time-dependent changes evaluated within 24 h treat-
ment; at 4, 8, 16 and 24 h. All experiments were carried out in trip-
licate cell culture plates and compared with non-treated cells.80 – 70.73
90 1.62, d (6.8) 59.47
100 – 37.40
110a 4.33, dd (10.3, 3.9) 66.19
110b 4.10, dd (10.3, 7)
120 1.07, s 21.94
130 0.71, s 24.38
140 0.80, s 28.68
150 0.92, s 15.63
2 – 15.91
3 6.1, d (9.1) 112.00
4 7.9, d (9.1) 144.18
5 7.7, d (8.8) 129.25
6 6.9, dd (8.8, 2.4) 113.11
7 – 161.80




80-OH 4.51 –3. Results and discussion
3.1. Spectroscopic characterization and theoretical studies
One crystalline sesquiterpene coumarin was isolated by column
chromatography method in Et2O extract. After recrystallization in
methanol and chloroform as well as booming attained crystals,
samarcandin was utterly characterized by spectroscopy and com-
parison with the literature data (see Fig. 1).
The spectroscopic data of samarcandin 1 showed strong simi-
larities to those of Badrakemin. The 1H NMR spectrum showed that
an extra methyl singlet in compound 1. It is noteworthy to note
that in the 13C NMR spectra of Badrakemin, the signals of two olfi-
nic carbons from (dC 107.6, CH2, and 146.7, C) were replaced by a
methyl group and a quaternary carbon at dC 21.9 and 70.7 in 1
[39]. The 1H NMR spectra of samarcandin exhibited resonances
of five methine signals at dH 6.1 (1H, d, J = 9.1 Hz), 7.9 (1H, d,
J = 9.1 Hz), 7.7 (1H, d, J = 8.8 Hz), 6.9 (1H, dd, J = 2.4, 8.8 Hz), and
7.0 (1H, d, J = 2.4 Hz) assigned to H3, H4, H5, H6, and H8 of the cou-
marin moiety, respectively. The methylene protons - H110a as well
as H110b - showed a different splitting than those reported in the lit-
erature with one of them appeared as double doublet signal at dH
4.33 (1H, dd, J = 10.3, 3.9 Hz), and with the second one appeared
as a doublet signal at dH 4.10 (1H, dd, J = 10.3, 7 Hz), respectively.
An additional oxygenated proton (H30 ) was found at dH 3.4 (brs).
The four methyl signals at dH 1.07 (s), 0.71 (s), 0.80 (s), and 0.92
(s) ppm were assigned to H120 , H130 , H140 , and H150 , respectively.
The 13C NMR spectrum (Table 1) showed signals for 24 carbons,
which were assigned with the aid of DEPT spectra to four methyl,
five methylene, eight methine, and seven quaternary carbons. Two
carbon resonances at dC 73.5 (CH) as well as 70.7 (C) suggested the
presence of oxygen-bearing sp3 carbons. The downfield signal at dC
161.8 ppm was assigned to the carbonyl carbon of the coumarin
moiety (C2) (see Table 1). In theoretical calculation, the 1H NMR
spectrum indicates that the values of H3, H4, H5, H6, and H8 peaks
are calculated to be 6.25, 7.94, 7.54, 6.89, and 7.16 ppm at the
B3LYP/6-311++G⁄⁄ level of theory, respectively. Our calculations
on 1H NMR imply an acceptable agreement with the experimental
values. The IR spectrum displayed the presence of hydroxyl
(3432 cm1), a-pyrone ring (1680 cm1), aromatic ring
(1589 cm1), aliphatic hydrogens (2925 cm1), and etheric oxygen
(1102 cm1). These data suggested that compound samarcandin
can be derived from sesquiterpene and umbelliferone components
[40]. The bonds between 1557 and 1684 cm1 are assigned to CAC
stretching vibration [41]. The C@O stretching bond is observed at
1770 cm1 in IR calculations. The vibrational analysis of this struc-
ture was carried out over the basis of the characteristic vibrations
methylene, hydroxyl, etheric oxygen, aliphatic hydrogens, and car-
bon aromatic ring modes. Theoretical calculations were done at the
B3LYP method and 6-311++G⁄⁄ standard basis set. The value of the
CAH stretching of the carbon aromatic ring occurs in the region
3196–3257 cm1. A band observed at 3490 cm1 in IR spectrumis assigned to hydroxyl stretching. The CAH stretching vibration
in a-pyrone ring occurs in the region 3022–3117 cm1. A peak
appearing at 1113 cm1 is assigned as CAO (etheric oxygen)
stretching vibration in IR spectrum. The UV spectrum of samarcan-
din exhibited two peaks in 326 nm and 244 nm wavelengths,
which can be related to C@O of coumarin part (C2) and double
bonds of aromatic ring, respectively. The time-dependent density
functional theory (TD-DFT) calculations were carried out by using
B3LYP functional and 6-311++G⁄⁄ standard basis set [42,43]. At
the present study the TD-DFT is computed by excited states oscil-
lator strengths for samarcandin within the gas phase. We observed
the three optical transitions for this compound, however, only two
terms contribute significantly to the oscillator strength: HOMO?
LUMO (H? L), with 95% of the 0.4665 oscillator strength and tran-
sition energy of 4.05 eV; and H-1? LUMO with 84% of the 0.0049
oscillator strength and transition energy of 4.33 eV. The theoretical
result reveals that the first excitation energy maximum is pre-
dicted at kmax = 316 nm with the 0.4665 oscillator strength that
is in excellent agreement with experimental measurement
(kmax = 326 nm). In the theoretical results, the second excitation
energy minimum is observed at kmax = 266 nm, while the experi-
mental data indicates the signal peak in the region of 244 nm.
3.2. Crystal structure of samarcandin
The crystal structure of samarcandin with the atom-numbering
scheme is presented in Fig. 2. Crystallographic data, details of the
data collection and structure solution and refinements are listed
in Table 2, while the selected bond distances, angles and torsion
angles are present in Table 3. The asymmetric unit consists of
one molecule of samarcandin and a fraction 0.094(4) of the lattice
water. The C4AO5 bond length of 1.2074 (19) Å matches the value
for double bond C@O, while the bonds C4AO3 (1.3729 (18)), C2AO3
(1.3823 (16)), C11AO12 (1.3553 (16)), C13AO12 (1.4439 (17)),
C15AO17 (1.4410 (17)), and C24AO25 (1.4282 (18) Å) correspond
Fig. 2. An ORTEP view of Samarcandin.
Table 2





Unit cell dimensions (Å) a = 10.8204 (5)
b = 12.9894 (7)
c = 15.2467 (9)
Volume (Å3) 2142.9 (2)
Z (atoms/unit cell) 4
Dcalc/g cm3 1.24595
T (K) 120.1 (5)
l (mm1) 0.09
F (0 0 0) 867.0
Crystal size (mm) 0.66  0.52  0.40
S 1.31
R[F2 > 3r(F2)] 0.033
wR(F2) 0.089
Dqmax 0.14
Dqmin (e Å3) 0.11
Table 3
Experimental selected bond distances, bond angles and dihedral angles of Samarcan-
din compared with its theoretical data.
Experimental Theoretical
B3LYP B-LYP B3PW91
C4AO3 1.37 (18) 1.37 1.37 1.37
C4AO5 1.21 (19) 1.20 1.20 1.21
C2AO3 1.38 (16) 1.38 1.38 1.38
C11AO12 1.36 (16) 1.36 1.37 1.35
O12AC13 1.44 (17) 1.44 1.46 1.43
C13AC14 1.53 (19) 1.54 1.57 1.53
C15AC16 1.52 (2) 1.53 1.54 1.53
C15AO17 1.44 (17) 1.45 1.47 1.44
C21AC22 1.54 (2) 1.55 1.56 1.54
C21AC23 1.53 (2) 1.54 1.56 1.54
C24AO25 1.43 (18) 1.44 1.46 1.43
C28AC29 1.54 (19) 1.55 1.56 1.54
O3AC4AO5 116.57 (13) 117.51 116.84 117.53
O5AC4AC6 126.03 (15) 126.47 127.46 126.36
C1AC11AO12 115.13 (12) 115.50 115.25 115.55
C10AC11AO12 124.41 (12) 124.33 124.52 124.27
C11AO12AC13 117.42 (10) 119.28 119.06 118.92
O12AC13AC14 107.73 (11) 108.31 108.14 108.39
C13AC14AC15 110.69 (11) 110.67 110.67 110.69
C13AC14AC28 114.74 (11) 115.37 115.46 115.23
C16AC15AO17 104.19 (11) 103.10 102.79 103.33
C22AC21AC23 107.20 (13) 106.74 106.71 106.84
C21AC24AO25 108.31 (11) 107.62 107.53 107.64
C21AC24AC26 112.59 (12) 113.10 113.26 112.86
O25AC24AC26 110.39 (11) 110.24 110.22 110.37
C14AC28AC20 106.27 (10) 106.21 106.17 106.19
C14AC28AC27 108.26 (10) 108.16 108.20 108.01
C14AC28AC29 111.63 (11) 111.71 111.63 111.73
C20AC28AC29 113.96 (11) 113.87 113.96 113.92
C27AC28AC29 108.80 (11) 108.62 108.68 108.73
C1AC11AO12AC13 174.13 179.66 179.83 179.46
O5AC4AC6AC7 175.38 179.81 179.78 179.80
C10AC11AO12AC13 5.68 0.45 0.28 0.65
C11AO12AC13AC14 178.90 178.14 177.93 178.71
O12AC13AC14AC15 135.63 137.49 136.55 136.59
O12AC13AC14AC28 91.37 88.71 89.52 89.64
C15AC14AC28AC29 69.57 69.12 69.39 68.94
O17AC15AC18AC19 168.98 167.44 167.31 167.84
C19AC20AC21AC22 59.54 58.75 58.80 58.68
C22AC21AC24AC26 168.88 170.46 170.09 170.85
C22AC21AC20AC28 168.88 169.44 169.21 169.68
C23AC21AC20AC28 71.08 70.54 70.82 70.17
1 For interpretation of color in Fig. 3, the reader is referred to the web version of
this article.
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(116.57 (13)) and O5AC4AC6 (126.03 (15)) in samarcandin are
consistent with the sp2 hybrid character of C4, while the bond
angles O12AC13AC14 (107.73 (11)) and C13AC14AC15 (110.69
(11)) in samarcandin are consistent with the sp3 hybrid character
of C13 and C14, respectively. Crystallographic data (excluding struc-
ture factors) for the structure reported in this paper has been
deposited with the Cambridge Crystallographic Centre, CCDC No.
1015760. Copies of the data could be obtained free of charge on
application to The Director, CCDC, 12 Union Road, Cambridge CB2
1EZ, UK, fax: +44 1223 336 033, e-mail: deposit@ccdc.cam.ac.uk or
http://www.ccdc.cam.ac.uk.
3.3. Theoretical analyses
The electronic densities in the HOMO (highest occupied molec-
ular orbital) and LUMO (lowest unoccupied molecular orbital) for
samarcandin was studied at the B3LYP, BLYP, and B3PW91 meth-
ods. Our calculations showed that the energy levels of HOMO
and LUMO are 6.34 and 1.99 eV (B3LYP), 5.43 and 2.55 eV
(BLYP), and 6.38 and 2.00 eV (B3PW91), respectively. As shown
in Fig. 3, the HOMO orbital of this molecule is primarily located on
the coumarin skeleton, O12 and C13, while the LUMO orbital is sit-
uated on the coumarin skeleton and O12. The HOMO-LUMO energy
separation has been interpreted as an indicator of kinetic stability
of the system [31,36]. The energy gap values of samarcandin is cal-
culated to be 4.35, 4.38, 2.88 eV at the B3LYP, BLYP, and B3PW91methods, respectively. The calculated HOMO–LUMO plots and
total electron density of samarcandin using 6-311++G⁄⁄ basis set
are shown in Fig. 3. The molecular electrostatic potential (MEP)
shows that oxygen atoms are negatively charged (red1 color) while
the hydrogen atoms of hydroxyl groups are positively charged (blue
color) (see Fig. 3).3.4. Cancer cell growth inhibition
To explore the biological activity of samarcandin against cancer
cell proliferation, the in vitro cytotoxicity was performed by study-
ing the cell morphology and MTT assay. The cytotoxicity of samar-
candin, with dendrosomal curcumin as positive control, was
studied in the following cancer cell lines: AGS (Human gastric car-
cinoma) and WEHI-164 (Skin from mouse fibrosarcoma). The IC50
value represents the amount of drug needed to inhibit 50% of the
cancer cell growth, and it was attained after 48 h of exposition.
The results displayed that samarcandin affects significantly the
viability of cancerous AGS and WEHI-164 cells with IC50 values
of 11 lM and 13 lM, respectively. In contrast, dendrosomal
Fig. 3. Distribution patterns of frontier molecular orbitals for Samarcandin using B3PW91/6-311++G⁄⁄ basis set.
(A) WEHI-164 without treatment (B) WEHI-164 with samarcandin treatment
Fig. 4. Morphologic changes of WEHI-164 cancerous cells; (A) without treatment, (B) treated by samarcandin (10 lM & 10 h). ⁄The black arrows exhibit the dead cancerous
cells.
S.H. Ghoran et al. / Bioorganic Chemistry 66 (2016) 27–32 31curcumin, as a positive control, shows the less cytotoxic effect than
samarcandin [34]. This anti-cancer effect at 0–200 lM concentra-
tions was detected in a time- and dose-dependent manner. Also,
the results revealed that the IC50 values for samarcandin were sig-
nificantly different from normal fibroblasts (120 lM). Meanwhile,
the morphology of cells treated with samarcandin has been altered
compared to the cells without any treatment (data not shown), see
Fig. 4. Microscopic data demonstrated represented that treating
cells with samarcandin causes abnormal morphological changes
like shrinkage in a time-dependent manner that lead to cellular
vesicles and finally ends in cell death. Our data are in concordance
with other similar reports showing the anti-cancer properties of
cyclic sesquiterpene-coumarins. According to recent studies fese-
lol, isolated from F. gumosa, illustrated potent antiproliferative
activity. It inhibited proliferation of leukemic cells (U937) with
IC50 value of 8 lM [17]. Rassouli et al. reported that the mogoltacin
existed in extract of F. Badrakema root showed more potent cyto-
toxic activity without any toxic effects on normal cells than vin-
cristine [18]. In another study, the extract of F. tunetana root
contained several sesquiterpene coumarins – coladonin andisosamarcandin –, which showed weak cytotoxic activity against
HTC 116 and HT-29 cell lines [19]. Thus, the purified samarcandin
is the most promising candidate for further in vitro and in vivo
studies.
4. Conclusion remarks
In summary, on account of increasing cancerous diseases, the
experts are clearly trying to find chemicals from herbal resources.
The chemical structure of samarcandin is based on a sesquiterpene
moiety linked through a linkage with the 7-hydroxy group of
umbelliferone skeleton. Samarcandin was isolated from F. assa-
foetida and characterized by FT-IR, UV, and NMR spectroscopies.
In addition, the absolute atomic structure of samarcandin was con-
firmed by single-crystal X-ray structure analysis. The optimized
molecular geometry and theoretical analysis with B3LYP and
B3PW91 basis sets of samarcandin make closely an agreement to
that obtained from the single crystal X-ray crystallography.
Through the calculations of the first ionization potentials, HOMO,
LUMO, and HOMO-LUMO gaps, it was found that samarcandin
32 S.H. Ghoran et al. / Bioorganic Chemistry 66 (2016) 27–32has low energy gaps between the first ionization potentials and
HOMO. It means that the low energy gap might responsible for
cytotoxic activity of samarcandin. Accurate theoretical calculations
can help identify and provide ways to obtain important chemical
and physical information that cannot be easily obtained by exper-
imental approaches. Furthermore, cellular toxicity was evaluated
by the MTT assay on cancerous AGS and WEHI-164 cell lines. In
conclusion, In vitro significant toxic effects as well as a noticeable
morphologic changes was observed by samarcandin treatment.
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